NCT03907215

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

A Single-center, Single-blind, Randomized, Placebo-controlled, Sequential Design Phase 1 Study With the Inclusion of Two Double-blind Nested Crossover Parts to Investigate the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Idorsia Pharmaceuticals Ltd. · Industry
• Sex: All
• Age: 24 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A clinical study to examine the drug-drug interactions between ACT-541468 and citalopram in healthy male and female subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	ACT541468	50 mg; film-coated tablet for oral use
DRUG	ACT541468 placebo	film-coated tablet for oral use
DRUG	Citalopram	20 mg; tablet tor oral use; for single- or repeated dosing

Timeline

• Start date: 2019-04-09
• Primary completion: 2019-06-26
• Completion: 2019-06-26
• First posted: 2019-04-08
• Last updated: 2019-10-31

Locations

1 site across 1 country: Germany

Regulatory

• FDA-regulated drug study